Immunotherapy and Combination Approaches Although MPNST is generally considered an immune-cold tumor, 2025 trials are combining PD-1 blockade with MEK inhibitors or radiation therapy to enhance immune activation
Importantly, these changes were short-lived
Recent studies have reported that the development of heart failure in adolescents is closely associated with a dramatic increase in DM, obesity, and metabolic dysfunction-associated steatotic liver disease (MASLD) (Wu et al., 2024
We built Nooms GLP-1 Companion, now with Muscle Defense, to be that program
HealthRX Review 2026: GLP-1 Weight Loss Program Pricing, Injectable vs Oral Options & Money-Back Guarantee Explained TLDR: HealthRX is a technology platform that connects patients with licensed providers who review intake information and may prescribe GLP-1 medications when clinically appropriate